ANGO Financial Facts
Total other income (expenses): -1.88MCost of sales: 40.37M
See Full Income Statement
Total current liabilities: 66.83M
COMMITMENTS AND CONTINGENCIES: 0
See Full Balance Sheet
Earnings History for AngioDynamics (ANGO)
|
Expand Research on ANGO
| Next EPS Date | 7/12/12 *Est. | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +8.7% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -8.1% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
1/3/13  |
 |
Q213 | $0.10 | $0.09 | +$0.01 | $87M | $87.4M | N/A / N/A | = | -2.2% | Details |
| 10/8/12 |
|
Q113 | $0.10 | $0.09 | +$0.01 | $83.4M | $84.35M | N/A / N/A | = | -13.8% | Details |
| 4/8/13 |
|
Q313 | $0.05 | $0.05 | $0.00 | $81.6M | $81.7M | N/A / N/A | = | +4.1% | Details |
| 7/14/11 |
|
Q411 | -$0.03 | $0.10 | -$0.13 | $56.4M | $56.96M | N/A / N/A | = | -22.4% | Details |
| 1/5/12 |
|
Q212 | $0.13 | $0.12 | +$0.01 | $53.4M | $56.26M | N/A / N/A | = | -25% | Details |
| 1/4/11 |
|
Q211 | $0.13 | $0.12 | +$0.01 | $53.4M | $54.37M | N/A / N/A | = | -28.8% | Details |
| 4/5/11 |
|
Q311 | $0.15 | $0.12 | +$0.03 | $54.6M | $53.89M | N/A / N/A | = | -26.9% | Details |
| 10/6/11 |
|
Q112 | $0.08 | $0.08 | $0.00 | $54.4M | $53.86M | N/A / N/A | = | -22% | Details |
